Search
for
Sort by
Research 151–180 of 1000+
- Transgenic mice overexpressing CD109 in the epidermis display decreased inflammation and granulation tissue and improved collagen architecture during wound healing
- miRNA microarray profiling in patients with androgenic alopecia and the effects of miR-133b on hair growth
- Sox9 expression in canine epithelial skin tumors
- The Thinning Top: Why Old People Have Less Hair
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- Novel immune mechanisms in androgenetic alopecia
- TGF-β family signaling in stem cells
- Potential targets in the discovery of new hair growth promoters for androgenic alopecia
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Roles of existing drug and drug targets for COVID-19 management
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- The PDGF/PDGFR pathway as a drug target
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- S100 signaling in hair follicle biology: emerging mechanistic insights and therapeutic opportunities
- Therapeutic strategies for treating hair loss
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- 570 Targeting phosphodiesterase 8A (PDE8A) to boost adipogenesis and hair regeneration
- Alopecia areata: from pathophysiology to therapeutic innovation
- Eph Receptors and Ephrins: Therapeutic Opportunities
- Mir-574-3p and Mir-125a-5p in Adipose Derived Mesenchymal Stem Cell Exosomes Synergistically Target TGF-β1/Smad2 Signaling Pathway for the Treatment of Androgenic Alopecia
- Recent approaches of antibody therapeutics in androgenetic alopecia
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Bazi Bushen capsule alleviates skin photoaging by targeting the KEAP1–NRF2 pathway
- DNMT1 targets SRD5A2 to induce mitochondrial homeostasis and EMT in urothelial cells of hypospadias
- Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF